Tag Archives: Lilly

Lilly scores FDA nod for new migraine drug Reyvow

Eli Lilly is already working to grow market share for its migraine prevention med Emgality, but now the company has a new medicine to add to its suite.  The drugmaker Friday won approval for Reyvow for the acute treatment of migraines as they occur. The drug, formerly known as lasmiditan, becomes the latest launch in Lilly’s pain and migraine franchise, which it bolstered… Read More »

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters. FILE PHOTO: The logo of Lilly is seen… Read More »

Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio

Last October, England’s drug-cost watchdogs dealt Eli Lilly a blow when they decreed that the company’s CDK 4/6 inhibitor to treat breast cancer, Verzenio, wasn’t cost-effective. So Lilly dished up a new price break—and now the National Institute for Health and Care Excellence (NICE) is on board. The problem, initially, was that Lilly couldn’t provide evidence that Verzenio… Read More »